Global Oral Solid Dosage CDMO Market Research Report 2026(Status and Outlook)
Oral solid dosage CDMO (Contract Development and Manufacturing Organization) is a professional outsourcing model that provides pharmaceutical companies with a full chain of services from drug research and development, process development, pilot scale-up, clinical sample production to commercial production. Its core lies in helping customers shorten the R&D cycle, reduce production costs, and achieve rapid transformation of products from laboratory to market through the integration of technology platforms and production capabilities.
The global Oral Solid Dosage CDMO market size was estimated at USD 1620.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 6.40% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Oral Solid Dosage CDMO market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Oral Solid Dosage CDMO market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Oral Solid Dosage CDMO market.
Global Oral Solid Dosage CDMO Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Adragos Pharma
Aenova
Agno Pharma
Alcami
Almac
Cambrex
Rubicon Research
Catalent Pharma Solutions
Hetero
Ind-Swift Laboratories
Lonza
PharmaSource
Recipharm
Rottendorf Pharma
Abbott
Skyepharma
Market Segmentation (by Type)
Chemical Drug CDMO
Biological Drug CDMO
Market Segmentation (by Application)
Ordinary Oral Solid Preparations
High-Activity and Special Preparations
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Oral Solid Dosage CDMO Market
Overview of the regional outlook of the Oral Solid Dosage CDMO Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Oral Solid Dosage CDMO Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Oral Solid Dosage CDMO, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
The global Oral Solid Dosage CDMO market size was estimated at USD 1620.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 6.40% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Oral Solid Dosage CDMO market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Oral Solid Dosage CDMO market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Oral Solid Dosage CDMO market.
Global Oral Solid Dosage CDMO Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Adragos Pharma
Aenova
Agno Pharma
Alcami
Almac
Cambrex
Rubicon Research
Catalent Pharma Solutions
Hetero
Ind-Swift Laboratories
Lonza
PharmaSource
Recipharm
Rottendorf Pharma
Abbott
Skyepharma
Market Segmentation (by Type)
Chemical Drug CDMO
Biological Drug CDMO
Market Segmentation (by Application)
Ordinary Oral Solid Preparations
High-Activity and Special Preparations
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Oral Solid Dosage CDMO Market
Overview of the regional outlook of the Oral Solid Dosage CDMO Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Oral Solid Dosage CDMO Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Oral Solid Dosage CDMO, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Oral Solid Dosage CDMO
1.2 Key Market Segments
1.2.1 Oral Solid Dosage CDMO Segment by Type
1.2.2 Oral Solid Dosage CDMO Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 ORAL SOLID DOSAGE CDMO MARKET OVERVIEW
2.1 Global Market Overview
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 ORAL SOLID DOSAGE CDMO MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Oral Solid Dosage CDMO Product Life Cycle
3.3 Global Oral Solid Dosage CDMO Revenue Market Share by Company (2020-2025)
3.4 Oral Solid Dosage CDMO Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.5 Headquarters, Areas Served, and Product Types of Major Players
3.6 Oral Solid Dosage CDMO Market Competitive Situation and Trends
3.6.1 Oral Solid Dosage CDMO Market Concentration Rate
3.6.2 Global 5 and 10 Largest Oral Solid Dosage CDMO Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 ORAL SOLID DOSAGE CDMO VALUE CHAIN ANALYSIS
4.1 Oral Solid Dosage CDMO Value Chain Analysis
4.2 Midstream Market Analysis
4.3 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF ORAL SOLID DOSAGE CDMO MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Oral Solid Dosage CDMO Market Porter's Five Forces Analysis
6 ORAL SOLID DOSAGE CDMO MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Oral Solid Dosage CDMO Market by Type (2020-2025)
6.3 Global Oral Solid Dosage CDMO Market Size Growth Rate by Type (2021-2025)
7 ORAL SOLID DOSAGE CDMO MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Oral Solid Dosage CDMO Market Size (M USD) by Application (2020-2025)
7.3 Global Oral Solid Dosage CDMO Market Size Growth Rate by Application (2021-2025)
8 ORAL SOLID DOSAGE CDMO MARKET SEGMENTATION BY REGION
8.1 Global Oral Solid Dosage CDMO Market Size by Region
8.1.1 Global Oral Solid Dosage CDMO Market Size by Region
8.1.2 Global Oral Solid Dosage CDMO Market Size Market Share by Region
8.2 North America
8.2.1 North America Oral Solid Dosage CDMO Market Size by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Oral Solid Dosage CDMO Market Size by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Spain
8.4 Asia Pacific
8.4.1 Asia Pacific Oral Solid Dosage CDMO Market Size by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Oral Solid Dosage CDMO Market Size by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Oral Solid Dosage CDMO Market Size by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Adragos Pharma
9.1.1 Adragos Pharma Basic Information
9.1.2 Adragos Pharma Oral Solid Dosage CDMO Product Overview
9.1.3 Adragos Pharma Oral Solid Dosage CDMO Product Market Performance
9.1.4 Adragos Pharma SWOT Analysis
9.1.5 Adragos Pharma Business Overview
9.1.6 Adragos Pharma Recent Developments
9.2 Aenova
9.2.1 Aenova Basic Information
9.2.2 Aenova Oral Solid Dosage CDMO Product Overview
9.2.3 Aenova Oral Solid Dosage CDMO Product Market Performance
9.2.4 Aenova SWOT Analysis
9.2.5 Aenova Business Overview
9.2.6 Aenova Recent Developments
9.3 Agno Pharma
9.3.1 Agno Pharma Basic Information
9.3.2 Agno Pharma Oral Solid Dosage CDMO Product Overview
9.3.3 Agno Pharma Oral Solid Dosage CDMO Product Market Performance
9.3.4 Agno Pharma SWOT Analysis
9.3.5 Agno Pharma Business Overview
9.3.6 Agno Pharma Recent Developments
9.4 Alcami
9.4.1 Alcami Basic Information
9.4.2 Alcami Oral Solid Dosage CDMO Product Overview
9.4.3 Alcami Oral Solid Dosage CDMO Product Market Performance
9.4.4 Alcami Business Overview
9.4.5 Alcami Recent Developments
9.5 Almac
9.5.1 Almac Basic Information
9.5.2 Almac Oral Solid Dosage CDMO Product Overview
9.5.3 Almac Oral Solid Dosage CDMO Product Market Performance
9.5.4 Almac Business Overview
9.5.5 Almac Recent Developments
9.6 Cambrex
9.6.1 Cambrex Basic Information
9.6.2 Cambrex Oral Solid Dosage CDMO Product Overview
9.6.3 Cambrex Oral Solid Dosage CDMO Product Market Performance
9.6.4 Cambrex Business Overview
9.6.5 Cambrex Recent Developments
9.7 Rubicon Research
9.7.1 Rubicon Research Basic Information
9.7.2 Rubicon Research Oral Solid Dosage CDMO Product Overview
9.7.3 Rubicon Research Oral Solid Dosage CDMO Product Market Performance
9.7.4 Rubicon Research Business Overview
9.7.5 Rubicon Research Recent Developments
9.8 Catalent Pharma Solutions
9.8.1 Catalent Pharma Solutions Basic Information
9.8.2 Catalent Pharma Solutions Oral Solid Dosage CDMO Product Overview
9.8.3 Catalent Pharma Solutions Oral Solid Dosage CDMO Product Market Performance
9.8.4 Catalent Pharma Solutions Business Overview
9.8.5 Catalent Pharma Solutions Recent Developments
9.9 Hetero
9.9.1 Hetero Basic Information
9.9.2 Hetero Oral Solid Dosage CDMO Product Overview
9.9.3 Hetero Oral Solid Dosage CDMO Product Market Performance
9.9.4 Hetero Business Overview
9.9.5 Hetero Recent Developments
9.10 Ind-Swift Laboratories
9.10.1 Ind-Swift Laboratories Basic Information
9.10.2 Ind-Swift Laboratories Oral Solid Dosage CDMO Product Overview
9.10.3 Ind-Swift Laboratories Oral Solid Dosage CDMO Product Market Performance
9.10.4 Ind-Swift Laboratories Business Overview
9.10.5 Ind-Swift Laboratories Recent Developments
9.11 Lonza
9.11.1 Lonza Basic Information
9.11.2 Lonza Oral Solid Dosage CDMO Product Overview
9.11.3 Lonza Oral Solid Dosage CDMO Product Market Performance
9.11.4 Lonza Business Overview
9.11.5 Lonza Recent Developments
9.12 PharmaSource
9.12.1 PharmaSource Basic Information
9.12.2 PharmaSource Oral Solid Dosage CDMO Product Overview
9.12.3 PharmaSource Oral Solid Dosage CDMO Product Market Performance
9.12.4 PharmaSource Business Overview
9.12.5 PharmaSource Recent Developments
9.13 Recipharm
9.13.1 Recipharm Basic Information
9.13.2 Recipharm Oral Solid Dosage CDMO Product Overview
9.13.3 Recipharm Oral Solid Dosage CDMO Product Market Performance
9.13.4 Recipharm Business Overview
9.13.5 Recipharm Recent Developments
9.14 Rottendorf Pharma
9.14.1 Rottendorf Pharma Basic Information
9.14.2 Rottendorf Pharma Oral Solid Dosage CDMO Product Overview
9.14.3 Rottendorf Pharma Oral Solid Dosage CDMO Product Market Performance
9.14.4 Rottendorf Pharma Business Overview
9.14.5 Rottendorf Pharma Recent Developments
9.15 Abbott
9.15.1 Abbott Basic Information
9.15.2 Abbott Oral Solid Dosage CDMO Product Overview
9.15.3 Abbott Oral Solid Dosage CDMO Product Market Performance
9.15.4 Abbott Business Overview
9.15.5 Abbott Recent Developments
9.16 Skyepharma
9.16.1 Skyepharma Basic Information
9.16.2 Skyepharma Oral Solid Dosage CDMO Product Overview
9.16.3 Skyepharma Oral Solid Dosage CDMO Product Market Performance
9.16.4 Skyepharma Business Overview
9.16.5 Skyepharma Recent Developments
10 ORAL SOLID DOSAGE CDMO MARKET FORECAST BY REGION
10.1 Global Oral Solid Dosage CDMO Market Size Forecast
10.2 Global Oral Solid Dosage CDMO Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Oral Solid Dosage CDMO Market Size Forecast by Country
10.2.3 Asia Pacific Oral Solid Dosage CDMO Market Size Forecast by Region
10.2.4 South America Oral Solid Dosage CDMO Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Sales of Oral Solid Dosage CDMO by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
11.1 Global Oral Solid Dosage CDMO Market Forecast by Type (2026-2035)
11.1.1 Global Oral Solid Dosage CDMO Market Size Forecast by Type (2026-2035)
11.2 Global Oral Solid Dosage CDMO Market Forecast by Application (2026-2035)
11.2.1 Global Oral Solid Dosage CDMO Market Size (M USD) Forecast by Application (2026-2035)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Oral Solid Dosage CDMO
1.2 Key Market Segments
1.2.1 Oral Solid Dosage CDMO Segment by Type
1.2.2 Oral Solid Dosage CDMO Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 ORAL SOLID DOSAGE CDMO MARKET OVERVIEW
2.1 Global Market Overview
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 ORAL SOLID DOSAGE CDMO MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Oral Solid Dosage CDMO Product Life Cycle
3.3 Global Oral Solid Dosage CDMO Revenue Market Share by Company (2020-2025)
3.4 Oral Solid Dosage CDMO Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.5 Headquarters, Areas Served, and Product Types of Major Players
3.6 Oral Solid Dosage CDMO Market Competitive Situation and Trends
3.6.1 Oral Solid Dosage CDMO Market Concentration Rate
3.6.2 Global 5 and 10 Largest Oral Solid Dosage CDMO Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 ORAL SOLID DOSAGE CDMO VALUE CHAIN ANALYSIS
4.1 Oral Solid Dosage CDMO Value Chain Analysis
4.2 Midstream Market Analysis
4.3 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF ORAL SOLID DOSAGE CDMO MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Oral Solid Dosage CDMO Market Porter's Five Forces Analysis
6 ORAL SOLID DOSAGE CDMO MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Oral Solid Dosage CDMO Market by Type (2020-2025)
6.3 Global Oral Solid Dosage CDMO Market Size Growth Rate by Type (2021-2025)
7 ORAL SOLID DOSAGE CDMO MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Oral Solid Dosage CDMO Market Size (M USD) by Application (2020-2025)
7.3 Global Oral Solid Dosage CDMO Market Size Growth Rate by Application (2021-2025)
8 ORAL SOLID DOSAGE CDMO MARKET SEGMENTATION BY REGION
8.1 Global Oral Solid Dosage CDMO Market Size by Region
8.1.1 Global Oral Solid Dosage CDMO Market Size by Region
8.1.2 Global Oral Solid Dosage CDMO Market Size Market Share by Region
8.2 North America
8.2.1 North America Oral Solid Dosage CDMO Market Size by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Oral Solid Dosage CDMO Market Size by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Spain
8.4 Asia Pacific
8.4.1 Asia Pacific Oral Solid Dosage CDMO Market Size by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Oral Solid Dosage CDMO Market Size by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Oral Solid Dosage CDMO Market Size by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Adragos Pharma
9.1.1 Adragos Pharma Basic Information
9.1.2 Adragos Pharma Oral Solid Dosage CDMO Product Overview
9.1.3 Adragos Pharma Oral Solid Dosage CDMO Product Market Performance
9.1.4 Adragos Pharma SWOT Analysis
9.1.5 Adragos Pharma Business Overview
9.1.6 Adragos Pharma Recent Developments
9.2 Aenova
9.2.1 Aenova Basic Information
9.2.2 Aenova Oral Solid Dosage CDMO Product Overview
9.2.3 Aenova Oral Solid Dosage CDMO Product Market Performance
9.2.4 Aenova SWOT Analysis
9.2.5 Aenova Business Overview
9.2.6 Aenova Recent Developments
9.3 Agno Pharma
9.3.1 Agno Pharma Basic Information
9.3.2 Agno Pharma Oral Solid Dosage CDMO Product Overview
9.3.3 Agno Pharma Oral Solid Dosage CDMO Product Market Performance
9.3.4 Agno Pharma SWOT Analysis
9.3.5 Agno Pharma Business Overview
9.3.6 Agno Pharma Recent Developments
9.4 Alcami
9.4.1 Alcami Basic Information
9.4.2 Alcami Oral Solid Dosage CDMO Product Overview
9.4.3 Alcami Oral Solid Dosage CDMO Product Market Performance
9.4.4 Alcami Business Overview
9.4.5 Alcami Recent Developments
9.5 Almac
9.5.1 Almac Basic Information
9.5.2 Almac Oral Solid Dosage CDMO Product Overview
9.5.3 Almac Oral Solid Dosage CDMO Product Market Performance
9.5.4 Almac Business Overview
9.5.5 Almac Recent Developments
9.6 Cambrex
9.6.1 Cambrex Basic Information
9.6.2 Cambrex Oral Solid Dosage CDMO Product Overview
9.6.3 Cambrex Oral Solid Dosage CDMO Product Market Performance
9.6.4 Cambrex Business Overview
9.6.5 Cambrex Recent Developments
9.7 Rubicon Research
9.7.1 Rubicon Research Basic Information
9.7.2 Rubicon Research Oral Solid Dosage CDMO Product Overview
9.7.3 Rubicon Research Oral Solid Dosage CDMO Product Market Performance
9.7.4 Rubicon Research Business Overview
9.7.5 Rubicon Research Recent Developments
9.8 Catalent Pharma Solutions
9.8.1 Catalent Pharma Solutions Basic Information
9.8.2 Catalent Pharma Solutions Oral Solid Dosage CDMO Product Overview
9.8.3 Catalent Pharma Solutions Oral Solid Dosage CDMO Product Market Performance
9.8.4 Catalent Pharma Solutions Business Overview
9.8.5 Catalent Pharma Solutions Recent Developments
9.9 Hetero
9.9.1 Hetero Basic Information
9.9.2 Hetero Oral Solid Dosage CDMO Product Overview
9.9.3 Hetero Oral Solid Dosage CDMO Product Market Performance
9.9.4 Hetero Business Overview
9.9.5 Hetero Recent Developments
9.10 Ind-Swift Laboratories
9.10.1 Ind-Swift Laboratories Basic Information
9.10.2 Ind-Swift Laboratories Oral Solid Dosage CDMO Product Overview
9.10.3 Ind-Swift Laboratories Oral Solid Dosage CDMO Product Market Performance
9.10.4 Ind-Swift Laboratories Business Overview
9.10.5 Ind-Swift Laboratories Recent Developments
9.11 Lonza
9.11.1 Lonza Basic Information
9.11.2 Lonza Oral Solid Dosage CDMO Product Overview
9.11.3 Lonza Oral Solid Dosage CDMO Product Market Performance
9.11.4 Lonza Business Overview
9.11.5 Lonza Recent Developments
9.12 PharmaSource
9.12.1 PharmaSource Basic Information
9.12.2 PharmaSource Oral Solid Dosage CDMO Product Overview
9.12.3 PharmaSource Oral Solid Dosage CDMO Product Market Performance
9.12.4 PharmaSource Business Overview
9.12.5 PharmaSource Recent Developments
9.13 Recipharm
9.13.1 Recipharm Basic Information
9.13.2 Recipharm Oral Solid Dosage CDMO Product Overview
9.13.3 Recipharm Oral Solid Dosage CDMO Product Market Performance
9.13.4 Recipharm Business Overview
9.13.5 Recipharm Recent Developments
9.14 Rottendorf Pharma
9.14.1 Rottendorf Pharma Basic Information
9.14.2 Rottendorf Pharma Oral Solid Dosage CDMO Product Overview
9.14.3 Rottendorf Pharma Oral Solid Dosage CDMO Product Market Performance
9.14.4 Rottendorf Pharma Business Overview
9.14.5 Rottendorf Pharma Recent Developments
9.15 Abbott
9.15.1 Abbott Basic Information
9.15.2 Abbott Oral Solid Dosage CDMO Product Overview
9.15.3 Abbott Oral Solid Dosage CDMO Product Market Performance
9.15.4 Abbott Business Overview
9.15.5 Abbott Recent Developments
9.16 Skyepharma
9.16.1 Skyepharma Basic Information
9.16.2 Skyepharma Oral Solid Dosage CDMO Product Overview
9.16.3 Skyepharma Oral Solid Dosage CDMO Product Market Performance
9.16.4 Skyepharma Business Overview
9.16.5 Skyepharma Recent Developments
10 ORAL SOLID DOSAGE CDMO MARKET FORECAST BY REGION
10.1 Global Oral Solid Dosage CDMO Market Size Forecast
10.2 Global Oral Solid Dosage CDMO Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Oral Solid Dosage CDMO Market Size Forecast by Country
10.2.3 Asia Pacific Oral Solid Dosage CDMO Market Size Forecast by Region
10.2.4 South America Oral Solid Dosage CDMO Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Sales of Oral Solid Dosage CDMO by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
11.1 Global Oral Solid Dosage CDMO Market Forecast by Type (2026-2035)
11.1.1 Global Oral Solid Dosage CDMO Market Size Forecast by Type (2026-2035)
11.2 Global Oral Solid Dosage CDMO Market Forecast by Application (2026-2035)
11.2.1 Global Oral Solid Dosage CDMO Market Size (M USD) Forecast by Application (2026-2035)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Oral Solid Dosage CDMO Market Size by Type (M USD)
Table 4. Global Oral Solid Dosage CDMO Market Size by Application
Table 5. Oral Solid Dosage CDMO Market Size Comparison by Region (M USD)
Table 6. Global Oral Solid Dosage CDMO Revenue (M USD) by Company (2020-2025)
Table 7. Global Oral Solid Dosage CDMO Revenue Share by Company (2020-2025)
Table 8. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oral Solid Dosage CDMO as of 2025)
Table 9. Headquarters, Areas Served, and Product Types of Major Players
Table 10. Product Type of Major Players
Table 11. Global Oral Solid Dosage CDMO Company Market Concentration Ratio (CR5 and HHI)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Midstream Market Analysis
Table 14. Downstream Customer Analysis
Table 15. Key Development Trends
Table 16. Driving Factors
Table 17. Oral Solid Dosage CDMO Market Challenges
Table 18. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 19. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 20. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 21. Global Oral Solid Dosage CDMO Market Size by Type (M USD)
Table 22. Global Oral Solid Dosage CDMO Market Size (M USD) by Type (2020-2025)
Table 23. Global Oral Solid Dosage CDMO Market Share by Type (2020-2025)
Table 24. Global Oral Solid Dosage CDMO Market Size Growth Rate by Type (2021-2025)
Table 25. Global Oral Solid Dosage CDMO Market Size by Application
Table 26. Global Oral Solid Dosage CDMO Market Size by Application (2020-2025) & (M USD)
Table 27. Global Oral Solid Dosage CDMO Market Share by Application (2020-2025)
Table 28. Global Oral Solid Dosage CDMO Market Size Growth Rate by Application (2021-2025)
Table 29. Global Oral Solid Dosage CDMO Market Size by Region (2020-2025) & (M USD)
Table 30. Global Oral Solid Dosage CDMO Market Size Market Share by Region (2020-2025)
Table 31. North America Oral Solid Dosage CDMO Market Size by Country (2020-2025) & (M USD)
Table 32. Europe Oral Solid Dosage CDMO Market Size by Country (2020-2025) & (M USD)
Table 33. Asia Pacific Oral Solid Dosage CDMO Market Size by Region (2020-2025) & (M USD)
Table 34. South America Oral Solid Dosage CDMO Market Size by Country (2020-2025) & (M USD)
Table 35. Middle East and Africa Oral Solid Dosage CDMO Market Size by Region (2020-2025) & (M USD)
Table 36. Adragos Pharma Basic Information
Table 37. Adragos Pharma Oral Solid Dosage CDMO Product Overview
Table 38. Adragos Pharma Oral Solid Dosage CDMO Revenue (M USD) and Gross Margin (2020-2025)
Table 39. Adragos Pharma SWOT Analysis
Table 40. Adragos Pharma Business Overview
Table 41. Adragos Pharma Recent Developments
Table 42. Aenova Basic Information
Table 43. Aenova Oral Solid Dosage CDMO Product Overview
Table 44. Aenova Oral Solid Dosage CDMO Revenue (M USD) and Gross Margin (2020-2025)
Table 45. Aenova SWOT Analysis
Table 46. Aenova Business Overview
Table 47. Aenova Recent Developments
Table 48. Agno Pharma Basic Information
Table 49. Agno Pharma Oral Solid Dosage CDMO Product Overview
Table 50. Agno Pharma Oral Solid Dosage CDMO Revenue (M USD) and Gross Margin (2020-2025)
Table 51. Agno Pharma SWOT Analysis
Table 52. Agno Pharma Business Overview
Table 53. Agno Pharma Recent Developments
Table 54. Alcami Basic Information
Table 55. Alcami Oral Solid Dosage CDMO Product Overview
Table 56. Alcami Oral Solid Dosage CDMO Revenue (M USD) and Gross Margin (2020-2025)
Table 57. Alcami Business Overview
Table 58. Alcami Recent Developments
Table 59. Almac Basic Information
Table 60. Almac Oral Solid Dosage CDMO Product Overview
Table 61. Almac Oral Solid Dosage CDMO Revenue (M USD) and Gross Margin (2020-2025)
Table 62. Almac Business Overview
Table 63. Almac Recent Developments
Table 64. Cambrex Basic Information
Table 65. Cambrex Oral Solid Dosage CDMO Product Overview
Table 66. Cambrex Oral Solid Dosage CDMO Revenue (M USD) and Gross Margin (2020-2025)
Table 67. Cambrex Business Overview
Table 68. Cambrex Recent Developments
Table 69. Rubicon Research Basic Information
Table 70. Rubicon Research Oral Solid Dosage CDMO Product Overview
Table 71. Rubicon Research Oral Solid Dosage CDMO Revenue (M USD) and Gross Margin (2020-2025)
Table 72. Rubicon Research Business Overview
Table 73. Rubicon Research Recent Developments
Table 74. Catalent Pharma Solutions Basic Information
Table 75. Catalent Pharma Solutions Oral Solid Dosage CDMO Product Overview
Table 76. Catalent Pharma Solutions Oral Solid Dosage CDMO Revenue (M USD) and Gross Margin (2020-2025)
Table 77. Catalent Pharma Solutions Business Overview
Table 78. Catalent Pharma Solutions Recent Developments
Table 79. Hetero Basic Information
Table 80. Hetero Oral Solid Dosage CDMO Product Overview
Table 81. Hetero Oral Solid Dosage CDMO Revenue (M USD) and Gross Margin (2020-2025)
Table 82. Hetero Business Overview
Table 83. Hetero Recent Developments
Table 84. Ind-Swift Laboratories Basic Information
Table 85. Ind-Swift Laboratories Oral Solid Dosage CDMO Product Overview
Table 86. Ind-Swift Laboratories Oral Solid Dosage CDMO Revenue (M USD) and Gross Margin (2020-2025)
Table 87. Ind-Swift Laboratories Business Overview
Table 88. Ind-Swift Laboratories Recent Developments
Table 89. Lonza Basic Information
Table 90. Lonza Oral Solid Dosage CDMO Product Overview
Table 91. Lonza Oral Solid Dosage CDMO Revenue (M USD) and Gross Margin (2020-2025)
Table 92. Lonza Business Overview
Table 93. Lonza Recent Developments
Table 94. PharmaSource Basic Information
Table 95. PharmaSource Oral Solid Dosage CDMO Product Overview
Table 96. PharmaSource Oral Solid Dosage CDMO Revenue (M USD) and Gross Margin (2020-2025)
Table 97. PharmaSource Business Overview
Table 98. PharmaSource Recent Developments
Table 99. Recipharm Basic Information
Table 100. Recipharm Oral Solid Dosage CDMO Product Overview
Table 101. Recipharm Oral Solid Dosage CDMO Revenue (M USD) and Gross Margin (2020-2025)
Table 102. Recipharm Business Overview
Table 103. Recipharm Recent Developments
Table 104. Rottendorf Pharma Basic Information
Table 105. Rottendorf Pharma Oral Solid Dosage CDMO Product Overview
Table 106. Rottendorf Pharma Oral Solid Dosage CDMO Revenue (M USD) and Gross Margin (2020-2025)
Table 107. Rottendorf Pharma Business Overview
Table 108. Rottendorf Pharma Recent Developments
Table 109. Abbott Basic Information
Table 110. Abbott Oral Solid Dosage CDMO Product Overview
Table 111. Abbott Oral Solid Dosage CDMO Revenue (M USD) and Gross Margin (2020-2025)
Table 112. Abbott Business Overview
Table 113. Abbott Recent Developments
Table 114. Skyepharma Basic Information
Table 115. Skyepharma Oral Solid Dosage CDMO Product Overview
Table 116. Skyepharma Oral Solid Dosage CDMO Revenue (M USD) and Gross Margin (2020-2025)
Table 117. Skyepharma Business Overview
Table 118. Skyepharma Recent Developments
Table 119. Global Oral Solid Dosage CDMO Market Size Forecast by Region (2026-2035) & (M USD)
Table 120. North America Oral Solid Dosage CDMO Market Size Forecast by Country (2026-2035) & (M USD)
Table 121. Europe Oral Solid Dosage CDMO Market Size Forecast by Country (2026-2035) & (M USD)
Table 122. Asia Pacific Oral Solid Dosage CDMO Market Size Forecast by Region (2026-2035) & (M USD)
Table 123. South America Oral Solid Dosage CDMO Market Size Forecast by Country (2026-2035) & (M USD)
Table 124. Middle East and Africa Oral Solid Dosage CDMO Market Size Forecast by Country (2026-2035) & (M USD)
Table 125. Global Oral Solid Dosage CDMO Market Size Forecast by Type (2026-2035) & (M USD)
Table 126. Global Oral Solid Dosage CDMO Market Size Forecast by Application (2026-2035) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Oral Solid Dosage CDMO Market Size by Type (M USD)
Table 4. Global Oral Solid Dosage CDMO Market Size by Application
Table 5. Oral Solid Dosage CDMO Market Size Comparison by Region (M USD)
Table 6. Global Oral Solid Dosage CDMO Revenue (M USD) by Company (2020-2025)
Table 7. Global Oral Solid Dosage CDMO Revenue Share by Company (2020-2025)
Table 8. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oral Solid Dosage CDMO as of 2025)
Table 9. Headquarters, Areas Served, and Product Types of Major Players
Table 10. Product Type of Major Players
Table 11. Global Oral Solid Dosage CDMO Company Market Concentration Ratio (CR5 and HHI)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Midstream Market Analysis
Table 14. Downstream Customer Analysis
Table 15. Key Development Trends
Table 16. Driving Factors
Table 17. Oral Solid Dosage CDMO Market Challenges
Table 18. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 19. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 20. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 21. Global Oral Solid Dosage CDMO Market Size by Type (M USD)
Table 22. Global Oral Solid Dosage CDMO Market Size (M USD) by Type (2020-2025)
Table 23. Global Oral Solid Dosage CDMO Market Share by Type (2020-2025)
Table 24. Global Oral Solid Dosage CDMO Market Size Growth Rate by Type (2021-2025)
Table 25. Global Oral Solid Dosage CDMO Market Size by Application
Table 26. Global Oral Solid Dosage CDMO Market Size by Application (2020-2025) & (M USD)
Table 27. Global Oral Solid Dosage CDMO Market Share by Application (2020-2025)
Table 28. Global Oral Solid Dosage CDMO Market Size Growth Rate by Application (2021-2025)
Table 29. Global Oral Solid Dosage CDMO Market Size by Region (2020-2025) & (M USD)
Table 30. Global Oral Solid Dosage CDMO Market Size Market Share by Region (2020-2025)
Table 31. North America Oral Solid Dosage CDMO Market Size by Country (2020-2025) & (M USD)
Table 32. Europe Oral Solid Dosage CDMO Market Size by Country (2020-2025) & (M USD)
Table 33. Asia Pacific Oral Solid Dosage CDMO Market Size by Region (2020-2025) & (M USD)
Table 34. South America Oral Solid Dosage CDMO Market Size by Country (2020-2025) & (M USD)
Table 35. Middle East and Africa Oral Solid Dosage CDMO Market Size by Region (2020-2025) & (M USD)
Table 36. Adragos Pharma Basic Information
Table 37. Adragos Pharma Oral Solid Dosage CDMO Product Overview
Table 38. Adragos Pharma Oral Solid Dosage CDMO Revenue (M USD) and Gross Margin (2020-2025)
Table 39. Adragos Pharma SWOT Analysis
Table 40. Adragos Pharma Business Overview
Table 41. Adragos Pharma Recent Developments
Table 42. Aenova Basic Information
Table 43. Aenova Oral Solid Dosage CDMO Product Overview
Table 44. Aenova Oral Solid Dosage CDMO Revenue (M USD) and Gross Margin (2020-2025)
Table 45. Aenova SWOT Analysis
Table 46. Aenova Business Overview
Table 47. Aenova Recent Developments
Table 48. Agno Pharma Basic Information
Table 49. Agno Pharma Oral Solid Dosage CDMO Product Overview
Table 50. Agno Pharma Oral Solid Dosage CDMO Revenue (M USD) and Gross Margin (2020-2025)
Table 51. Agno Pharma SWOT Analysis
Table 52. Agno Pharma Business Overview
Table 53. Agno Pharma Recent Developments
Table 54. Alcami Basic Information
Table 55. Alcami Oral Solid Dosage CDMO Product Overview
Table 56. Alcami Oral Solid Dosage CDMO Revenue (M USD) and Gross Margin (2020-2025)
Table 57. Alcami Business Overview
Table 58. Alcami Recent Developments
Table 59. Almac Basic Information
Table 60. Almac Oral Solid Dosage CDMO Product Overview
Table 61. Almac Oral Solid Dosage CDMO Revenue (M USD) and Gross Margin (2020-2025)
Table 62. Almac Business Overview
Table 63. Almac Recent Developments
Table 64. Cambrex Basic Information
Table 65. Cambrex Oral Solid Dosage CDMO Product Overview
Table 66. Cambrex Oral Solid Dosage CDMO Revenue (M USD) and Gross Margin (2020-2025)
Table 67. Cambrex Business Overview
Table 68. Cambrex Recent Developments
Table 69. Rubicon Research Basic Information
Table 70. Rubicon Research Oral Solid Dosage CDMO Product Overview
Table 71. Rubicon Research Oral Solid Dosage CDMO Revenue (M USD) and Gross Margin (2020-2025)
Table 72. Rubicon Research Business Overview
Table 73. Rubicon Research Recent Developments
Table 74. Catalent Pharma Solutions Basic Information
Table 75. Catalent Pharma Solutions Oral Solid Dosage CDMO Product Overview
Table 76. Catalent Pharma Solutions Oral Solid Dosage CDMO Revenue (M USD) and Gross Margin (2020-2025)
Table 77. Catalent Pharma Solutions Business Overview
Table 78. Catalent Pharma Solutions Recent Developments
Table 79. Hetero Basic Information
Table 80. Hetero Oral Solid Dosage CDMO Product Overview
Table 81. Hetero Oral Solid Dosage CDMO Revenue (M USD) and Gross Margin (2020-2025)
Table 82. Hetero Business Overview
Table 83. Hetero Recent Developments
Table 84. Ind-Swift Laboratories Basic Information
Table 85. Ind-Swift Laboratories Oral Solid Dosage CDMO Product Overview
Table 86. Ind-Swift Laboratories Oral Solid Dosage CDMO Revenue (M USD) and Gross Margin (2020-2025)
Table 87. Ind-Swift Laboratories Business Overview
Table 88. Ind-Swift Laboratories Recent Developments
Table 89. Lonza Basic Information
Table 90. Lonza Oral Solid Dosage CDMO Product Overview
Table 91. Lonza Oral Solid Dosage CDMO Revenue (M USD) and Gross Margin (2020-2025)
Table 92. Lonza Business Overview
Table 93. Lonza Recent Developments
Table 94. PharmaSource Basic Information
Table 95. PharmaSource Oral Solid Dosage CDMO Product Overview
Table 96. PharmaSource Oral Solid Dosage CDMO Revenue (M USD) and Gross Margin (2020-2025)
Table 97. PharmaSource Business Overview
Table 98. PharmaSource Recent Developments
Table 99. Recipharm Basic Information
Table 100. Recipharm Oral Solid Dosage CDMO Product Overview
Table 101. Recipharm Oral Solid Dosage CDMO Revenue (M USD) and Gross Margin (2020-2025)
Table 102. Recipharm Business Overview
Table 103. Recipharm Recent Developments
Table 104. Rottendorf Pharma Basic Information
Table 105. Rottendorf Pharma Oral Solid Dosage CDMO Product Overview
Table 106. Rottendorf Pharma Oral Solid Dosage CDMO Revenue (M USD) and Gross Margin (2020-2025)
Table 107. Rottendorf Pharma Business Overview
Table 108. Rottendorf Pharma Recent Developments
Table 109. Abbott Basic Information
Table 110. Abbott Oral Solid Dosage CDMO Product Overview
Table 111. Abbott Oral Solid Dosage CDMO Revenue (M USD) and Gross Margin (2020-2025)
Table 112. Abbott Business Overview
Table 113. Abbott Recent Developments
Table 114. Skyepharma Basic Information
Table 115. Skyepharma Oral Solid Dosage CDMO Product Overview
Table 116. Skyepharma Oral Solid Dosage CDMO Revenue (M USD) and Gross Margin (2020-2025)
Table 117. Skyepharma Business Overview
Table 118. Skyepharma Recent Developments
Table 119. Global Oral Solid Dosage CDMO Market Size Forecast by Region (2026-2035) & (M USD)
Table 120. North America Oral Solid Dosage CDMO Market Size Forecast by Country (2026-2035) & (M USD)
Table 121. Europe Oral Solid Dosage CDMO Market Size Forecast by Country (2026-2035) & (M USD)
Table 122. Asia Pacific Oral Solid Dosage CDMO Market Size Forecast by Region (2026-2035) & (M USD)
Table 123. South America Oral Solid Dosage CDMO Market Size Forecast by Country (2026-2035) & (M USD)
Table 124. Middle East and Africa Oral Solid Dosage CDMO Market Size Forecast by Country (2026-2035) & (M USD)
Table 125. Global Oral Solid Dosage CDMO Market Size Forecast by Type (2026-2035) & (M USD)
Table 126. Global Oral Solid Dosage CDMO Market Size Forecast by Application (2026-2035) & (M USD)
LIST OF FIGURES
Figure 1. Industry Chain of Oral Solid Dosage CDMO
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Oral Solid Dosage CDMO Market Size (M USD), 2025-2035
Figure 5. Global Oral Solid Dosage CDMO Market Size (M USD) (2020-2035)
Figure 6. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 8. Evaluation Matrix of Regional Market Development Potential
Figure 9. Oral Solid Dosage CDMO Market Size by Country (M USD)
Figure 10. Company Assessment Quadrant
Figure 11. Global Oral Solid Dosage CDMO Product Life Cycle
Figure 12. Global Oral Solid Dosage CDMO Revenue Share by Company in 2025
Figure 13. Oral Solid Dosage CDMO Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 14. The Global 5 and 10 Largest Players: Market Share by Oral Solid Dosage CDMO Revenue in 2025
Figure 15. Value Chain Map of Oral Solid Dosage CDMO
Figure 16. Global Oral Solid Dosage CDMO Market PEST Analysis
Figure 17. Global Oral Solid Dosage CDMO Market Porter's Five Forces Analysis
Figure 18. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 19. Global Oral Solid Dosage CDMO Market Share by Type
Figure 20. Market Share of Oral Solid Dosage CDMO by Type (2020-2025)
Figure 21. Global Oral Solid Dosage CDMO Market Size Growth Rate by Type (2021-2025)
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Oral Solid Dosage CDMO Market Share by Application
Figure 24. Global Oral Solid Dosage CDMO Market Share by Application (2020-2025)
Figure 25. Global Oral Solid Dosage CDMO Market Share by Application in 2024
Figure 26. Global Oral Solid Dosage CDMO Market Size Growth Rate by Application (2021-2025)
Figure 27. Global Oral Solid Dosage CDMO Market Size Market Share by Region (2020-2025)
Figure 28. North America Oral Solid Dosage CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 29. North America Oral Solid Dosage CDMO Market Size Market Share by Country in 2024
Figure 30. U.S. Oral Solid Dosage CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 31. Canada Oral Solid Dosage CDMO Market Size (M USD) and Growth Rate (2020-2025)
Figure 32. Mexico Oral Solid Dosage CDMO Market Size (M USD) and Growth Rate (2020-2025)
Figure 33. Europe Oral Solid Dosage CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 34. Europe Oral Solid Dosage CDMO Market Share by Country in 2024
Figure 35. Germany Oral Solid Dosage CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 36. France Oral Solid Dosage CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 37. U.K. Oral Solid Dosage CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 38. Italy Oral Solid Dosage CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 39. Spain Oral Solid Dosage CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 40. Asia Pacific Oral Solid Dosage CDMO Market Size and Growth Rate (M USD)
Figure 41. Asia Pacific Oral Solid Dosage CDMO Market Size Market Share by Region in 2024
Figure 42. China Oral Solid Dosage CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 43. Japan Oral Solid Dosage CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. South Korea Oral Solid Dosage CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 45. India Oral Solid Dosage CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 46. Southeast Asia Oral Solid Dosage CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. South America Oral Solid Dosage CDMO Market Size and Growth Rate (M USD)
Figure 48. South America Oral Solid Dosage CDMO Market Size Market Share by Country in 2024
Figure 49. Brazil Oral Solid Dosage CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 50. Argentina Oral Solid Dosage CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 51. Columbia Oral Solid Dosage CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 52. Middle East and Africa Oral Solid Dosage CDMO Market Size and Growth Rate (M USD)
Figure 53. Middle East and Africa Oral Solid Dosage CDMO Market Size Market Share by Region in 2024
Figure 54. Saudi Arabia Oral Solid Dosage CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 55. UAE Oral Solid Dosage CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 56. Egypt Oral Solid Dosage CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. Nigeria Oral Solid Dosage CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 58. South Africa Oral Solid Dosage CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. Global Oral Solid Dosage CDMO Market Size Forecast by Value (2020-2035) & (M USD)
Figure 60. Global Oral Solid Dosage CDMO Market Share Forecast by Type (2026-2035)
Figure 61. Global Oral Solid Dosage CDMO Market Share Forecast by Application (2026-2035)
Figure 1. Industry Chain of Oral Solid Dosage CDMO
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Oral Solid Dosage CDMO Market Size (M USD), 2025-2035
Figure 5. Global Oral Solid Dosage CDMO Market Size (M USD) (2020-2035)
Figure 6. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 8. Evaluation Matrix of Regional Market Development Potential
Figure 9. Oral Solid Dosage CDMO Market Size by Country (M USD)
Figure 10. Company Assessment Quadrant
Figure 11. Global Oral Solid Dosage CDMO Product Life Cycle
Figure 12. Global Oral Solid Dosage CDMO Revenue Share by Company in 2025
Figure 13. Oral Solid Dosage CDMO Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 14. The Global 5 and 10 Largest Players: Market Share by Oral Solid Dosage CDMO Revenue in 2025
Figure 15. Value Chain Map of Oral Solid Dosage CDMO
Figure 16. Global Oral Solid Dosage CDMO Market PEST Analysis
Figure 17. Global Oral Solid Dosage CDMO Market Porter's Five Forces Analysis
Figure 18. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 19. Global Oral Solid Dosage CDMO Market Share by Type
Figure 20. Market Share of Oral Solid Dosage CDMO by Type (2020-2025)
Figure 21. Global Oral Solid Dosage CDMO Market Size Growth Rate by Type (2021-2025)
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Oral Solid Dosage CDMO Market Share by Application
Figure 24. Global Oral Solid Dosage CDMO Market Share by Application (2020-2025)
Figure 25. Global Oral Solid Dosage CDMO Market Share by Application in 2024
Figure 26. Global Oral Solid Dosage CDMO Market Size Growth Rate by Application (2021-2025)
Figure 27. Global Oral Solid Dosage CDMO Market Size Market Share by Region (2020-2025)
Figure 28. North America Oral Solid Dosage CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 29. North America Oral Solid Dosage CDMO Market Size Market Share by Country in 2024
Figure 30. U.S. Oral Solid Dosage CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 31. Canada Oral Solid Dosage CDMO Market Size (M USD) and Growth Rate (2020-2025)
Figure 32. Mexico Oral Solid Dosage CDMO Market Size (M USD) and Growth Rate (2020-2025)
Figure 33. Europe Oral Solid Dosage CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 34. Europe Oral Solid Dosage CDMO Market Share by Country in 2024
Figure 35. Germany Oral Solid Dosage CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 36. France Oral Solid Dosage CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 37. U.K. Oral Solid Dosage CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 38. Italy Oral Solid Dosage CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 39. Spain Oral Solid Dosage CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 40. Asia Pacific Oral Solid Dosage CDMO Market Size and Growth Rate (M USD)
Figure 41. Asia Pacific Oral Solid Dosage CDMO Market Size Market Share by Region in 2024
Figure 42. China Oral Solid Dosage CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 43. Japan Oral Solid Dosage CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. South Korea Oral Solid Dosage CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 45. India Oral Solid Dosage CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 46. Southeast Asia Oral Solid Dosage CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. South America Oral Solid Dosage CDMO Market Size and Growth Rate (M USD)
Figure 48. South America Oral Solid Dosage CDMO Market Size Market Share by Country in 2024
Figure 49. Brazil Oral Solid Dosage CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 50. Argentina Oral Solid Dosage CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 51. Columbia Oral Solid Dosage CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 52. Middle East and Africa Oral Solid Dosage CDMO Market Size and Growth Rate (M USD)
Figure 53. Middle East and Africa Oral Solid Dosage CDMO Market Size Market Share by Region in 2024
Figure 54. Saudi Arabia Oral Solid Dosage CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 55. UAE Oral Solid Dosage CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 56. Egypt Oral Solid Dosage CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. Nigeria Oral Solid Dosage CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 58. South Africa Oral Solid Dosage CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. Global Oral Solid Dosage CDMO Market Size Forecast by Value (2020-2035) & (M USD)
Figure 60. Global Oral Solid Dosage CDMO Market Share Forecast by Type (2026-2035)
Figure 61. Global Oral Solid Dosage CDMO Market Share Forecast by Application (2026-2035)
